Photonis
MARCO ISLAND, FL / ACCESSWIRE / July 30, 2024 / Photonis, part of Exosens, a leading global provider of neutron and gamma detectors for the nuclear industry, announces its participation at the American Nuclear Society's Utility Working Conference and Vendor Technology Expo from August 4-7, 2024, in Marco Island, Florida. This event marks Photonis' strategic initiative to expand its presence in the U.S. market, showcasing its commitment to delivering high-quality, customized solutions tailored to the unique needs of the nuclear industry.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.With over 50 years of experience designing and manufacturing nuclear instrumentation for French nuclear power plants and research programs, Photonis brings a wealth of expertise to the American market. The company's comprehensive catalog of nuclear components includes market-leading technology such as High-Temperature In-Core and Ex-Core Fission Chambers, Miniature Gamma Ionization Chambers, and High-Sensitivity Boron-Lined Proportional Counters. Also featured are Mineral Insulated Cable Extensions and Connectors, highlighting Photonis' capability in product development and adaptation.
This extensive experience and innovative product range have earned Photonis a reputation as a trusted partner in the nuclear industry, with customers relying on its nuclear instrumentation in over 180 nuclear power plants worldwide. Additionally, Photonis is a critical component supplier for the French Alternative Energies and Atomic Energy Commission (CEA), further solidifying its reputation as a leading provider of high-quality nuclear detection solutions.
Photonis' neutron and gamma detectors play a crucial role in ensuring safety and control of nuclear reactors, fuel reprocessing plants, radioactive waste storage, and nuclear research facilities worldwide. By expanding its presence in the U.S. market, Photonis aims to establish itself as a trusted partner capable of delivering high-quality, tailored solutions that meet the evolving needs of industry stakeholders.
"We are thrilled to participate in the ANS Utility Working Conference and introduce our advanced nuclear instrumentation solutions to the U.S. market. Photonis is dedicated to meeting the stringent safety and regulatory requirements of the nuclear industry and to becoming one of the major solutions providers in the North American market. We look forward to engaging with U.S. customers and demonstrating how our technologies can enhance the safety and efficiency of their operations," said Ulrich Laupper, President and Executive General Manager of the Ultimate Detection Business Unit of Exosens.
The company's commitment to excellence is underscored by its dedicated Research and Development team, operating under ISO9001, ISO19443, RCCE (EDF Rules), ASME NQA-1, and HAF604 certifications, ensuring rigorous quality standards across all operations.
Attendees of the ANS Utility Working Conference are invited to visit Photonis at booth #105 to explore its wide range of innovative nuclear instrumentation solutions and discuss partnership opportunities.
ABOUT PHOTONIS:
Photonis is a leading product brand of Exosens, a high-tech company with more than 85 years of experience in the innovation, development, manufacture and sale of high-end electro-optical technologies. Photonis offers its customers photo-detection and low-light conditions imaging solutions for extremely demanding environments such as Defense & Security, Nuclear Safety, Life Science and Industrial & Non-Destructive testing. Photonis is internationally recognized as a leading brand and a major innovator in its fields with production and R&D sites in Europe and North America.
For more information: exosens.com.
Contact Information:
Sales Manager
Nuclear Instrumentation Sales Manager - North America
nuclearsales@exosens.com
508-744-8769
SOURCE: Photonis Scientific, Inc.
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Formerra to Supply Foster Medical Compounds Across the Americas15.7.2025 16:45:00 CEST | Press release
Following GEON's acquisition of Foster, LLC, this new agreement expands Formerra's healthcare polymer portfolio with life-saving medical compounds. ROMEOVILLE, IL / ACCESS Newswire / July 15, 2025 / Formerra, a leader in performance materials distribution, today announced an agreement with GEON® Performance Solutions that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in North America and South America. The agreement follows GEON's acquisition of Foster, LLC, and builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "This expanded partnership equips our customers with a broader set of proven medical-grade solutions while leveraging Formerra's technical guidance and robust supply-chain capabilities," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Foster's brand strength and GEON's investment momentum create powerful growth potential for these materials and our cust
FairWinds Migrates from .COM to .FAIRWINDS, Showcasing Leadership in Strategic Internet Addressing15.7.2025 16:00:00 CEST | Press release
WASHINGTON, DC / ACCESS Newswire / July 15, 2025 / FairWinds Partners, the world's leading domain name strategy consultancy, has completed the migration of its website from fairwindspartners.com to home.fairwinds. "This transition is more than a domain change. It reflects our belief in the future of .BRAND top-level domains," said FairWinds founder Josh Bourne. "Our move to .FAIRWINDS reinforces the strategic value that these top-level domains offer and our evolution from a pioneering domain name advisory firm to the trusted partner for global brands navigating the digital landscape via the address bar." Unlike second-level domains like google.com, top-level domains reside on the internet's root servers -- the foundation of the internet's naming system. .BRAND top-level domains are not publicly available and are used exclusively by the brand owner. ".BRAND top-level domains provide a powerful way to amplify, control, and secure a brand's digital presence while giving visitors visual pr
QorusDocs Reports 360% Increase in Customers Using AI to Manage Proposals, Acquires Shark Finesse to Build Unified AI-Powered Value and Proposal Platform15.7.2025 13:00:00 CEST | Press release
BELLEVUE, WA / ACCESS Newswire / July 15, 2025 / QorusDocs, an AI-powered proposal management software company that streamlines creation of pitches, proposals and request for proposal (RFP) responses, today announced that its customers' use of AI to manage proposals has grown 360% year over year, and that it has acquired Shark Finesse Ltd, a United Kingdom-based AI-powered customer value management software. "AI is completely transforming how business development teams win business, and QorusDocs is at the forefront," said Ray Meiring, CEO of QorusDocs. "The majority of our customers now rely on AI to manage proposals. We're at a pivotal moment, and with the acquisition of Shark Finesse, we're poised to deliver on companies' full revenue enablement journey, from proving value to winning the deal." QorusDocs Acquires Shark Finesse With Shark Finesse joining QorusDocs, the company's vision is to enable business development and proposal teams to prove value early in the revenue cycle, wit
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease15.7.2025 09:50:00 CEST | Press release
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB).AATec Medical and Northway Biotech Announce Partnership Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-
IXOPAY Surges Past 500 Certified Adapters, Solidifies Leadership in Enterprise-Grade Payment Orchestration15.7.2025 06:00:00 CEST | Press release
With 200 PSPs and 300 payment methods, IXOPAY is unlocking faster global expansion, improved approval rates, and full-stack control for enterprise merchants. LEHI, UT / ACCESS Newswire / July 15, 2025 / As global commerce accelerates, enterprise merchants are hitting a wall - their legacy payment stacks weren't built for the scale, complexity, or speed modern commerce demands. To stay competitive, merchants need infrastructure that adapts across markets, providers, and payment methods without costly rewrites or vendor lock-in. IXOPAY, a global leader in enterprise-grade payment orchestration, is addressing that challenge head-on with the announcement it has reached 500 certified adapters, connecting 200 payment service providers (PSPs) and 300 payment methods through a single, vendor-agnostic API. Payment orchestration is rapidly emerging as vital infrastructure for modern payments, and its effectiveness depends on the scale and breadth of the adapter ecosystem. IXOPAY's industry-leadi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom